[{"address1": "910 Clopper Road", "address2": "Suite 201S", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 654 1450", "website": "https://altimmune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vipin K. Garg Ph.D.", "age": 66, "title": "President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 992999, "exercisedValue": 0, "unexercisedValue": 1959778}, {"maxAge": 1, "name": "Dr. M. Scot Roberts Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 648960, "exercisedValue": 0, "unexercisedValue": 290514}, {"maxAge": 1, "name": "Dr. Matthew Scott Harris AGAF, FCAP, M.D., MS", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 690737, "exercisedValue": 0, "unexercisedValue": 709666}, {"maxAge": 1, "name": "Mr. Gregory L. Weaver CPA, M.B.A.", "age": 68, "title": "Chief Financial Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Shutterly M.S.", "age": 35, "title": "Principal Financial & Accounting Officer and Corporate Controller", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bertrand  Georges Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Blandin B.S.", "title": "Vice President of Quality & Compliance Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raymond M. Jordt M.B.A.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 578850, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.46, "open": 4.28, "dayLow": 4.13, "dayHigh": 4.4385, "regularMarketPreviousClose": 4.46, "regularMarketOpen": 4.28, "regularMarketDayLow": 4.13, "regularMarketDayHigh": 4.4385, "exDividendDate": 1484870400, "payoutRatio": 0.0, "beta": 0.891, "forwardPE": -2.8843536, "volume": 2960481, "regularMarketVolume": 2960481, "averageVolume": 2522633, "averageVolume10days": 2211780, "averageDailyVolume10Day": 2211780, "bid": 4.21, "ask": 4.27, "bidSize": 3, "askSize": 14, "marketCap": 326538048, "fiftyTwoWeekLow": 4.13, "fiftyTwoWeekHigh": 11.16, "priceToSalesTrailing12Months": 16326.902, "fiftyDayAverage": 6.021, "twoHundredDayAverage": 6.864475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 196327904, "profitMargins": 0.0, "floatShares": 76335168, "sharesOutstanding": 77013696, "sharesShort": 22452019, "sharesShortPriorMonth": 22472098, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.2915, "heldPercentInsiders": 0.00801, "heldPercentInstitutions": 0.53698003, "shortRatio": 7.0, "shortPercentOfFloat": 0.29389998, "impliedSharesOutstanding": 77013696, "bookValue": 1.707, "priceToBook": 2.4838898, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -95059000, "trailingEps": -1.34, "forwardEps": -1.47, "lastSplitFactor": "1:30", "lastSplitDate": 1536883200, "enterpriseToRevenue": 9816.395, "enterpriseToEbitda": -1.907, "52WeekChange": -0.5075494, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 4.24, "targetHighPrice": 28.0, "targetLowPrice": 12.0, "targetMeanPrice": 22.375, "targetMedianPrice": 25.0, "recommendationMean": 1.55556, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 131891000, "totalCashPerShare": 1.713, "ebitda": -102934000, "totalDebt": 1681000, "quickRatio": 12.897, "currentRatio": 13.112, "totalRevenue": 20000, "debtToEquity": 1.361, "revenuePerShare": 0.0, "returnOnAssets": -0.36853, "returnOnEquity": -0.59860003, "grossProfits": -82206000, "freeCashflow": -44867124, "operatingCashflow": -79848000, "revenueGrowth": -0.865, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -4973.2, "financialCurrency": "USD", "symbol": "ALT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1743810858, "regularMarketTime": 1743796800, "exchange": "NGM", "messageBoardId": "finmb_4866807", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Altimmune, Inc.", "longName": "Altimmune, Inc.", "regularMarketChangePercent": -4.9327416, "regularMarketPrice": 4.24, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746621000, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.34, "epsForward": -1.47, "epsCurrentYear": -1.08737, "priceEpsCurrentYear": -3.8993163, "fiftyDayAverageChange": -1.7810001, "fiftyDayAverageChangePercent": -0.29579806, "twoHundredDayAverageChange": -2.624475, "twoHundredDayAverageChangePercent": -0.38232714, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1495805400000, "postMarketChangePercent": 1.4151, "postMarketPrice": 4.3, "postMarketChange": 0.0600004, "regularMarketChange": -0.22000027, "regularMarketDayRange": "4.13 - 4.4385", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2522633, "fiftyTwoWeekLowChange": 0.10999966, "fiftyTwoWeekLowChangePercent": 0.026634298, "fiftyTwoWeekRange": "4.13 - 11.16", "fiftyTwoWeekHighChange": -6.92, "fiftyTwoWeekHighChangePercent": -0.6200717, "fiftyTwoWeekChangePercent": -50.75494, "dividendDate": 1536883200, "displayName": "Altimmune", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]